Early research (Phase 1)UnknownNCT02500680
What this trial is testing
The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)
Who this might be right for
Influenza, Human
Nova Immunotherapeutics Limited 102